Indivior Pharmaceuticals, Inc. (INDV)
34.95
+0.08
(+0.23%)
USD |
NASDAQ |
Aug 31, 16:00
34.95
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Cash from Operations (TTM) : -48.64M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -48.64M |
| March 31, 2026 | -111.25M |
| December 31, 2025 | -27.25M |
| September 30, 2025 | 182.28M |
| June 30, 2025 | 227.14M |
| March 31, 2025 | 148.11M |
| December 31, 2024 | 36.11M |
| September 30, 2024 | -227.44M |
| June 30, 2024 | -208.74M |
| March 31, 2024 | -314.36M |
| December 31, 2023 | -313.36M |
| September 30, 2023 | -49.80M |
| June 30, 2023 | -14.99M |
| March 31, 2023 | 27.46M |
| December 31, 2022 | -11.54M |
| September 30, 2022 | 169.64M |
| June 30, 2022 | 139.94M |
| March 31, 2022 | 187.10M |
| December 31, 2021 | 351.10M |
| September 30, 2021 | 114.48M |
| June 30, 2021 | 115.69M |
| March 31, 2021 | 40.78M |
| Date | Value |
|---|---|
| December 31, 2020 | -194.22M |
| September 30, 2020 | -81.97M |
| June 30, 2020 | -71.07M |
| March 31, 2020 | -128.72M |
| December 31, 2019 | 152.28M |
| September 30, 2019 | 200.56M |
| June 30, 2019 | 273.52M |
| March 31, 2019 | 409.65M |
| December 31, 2018 | 299.65M |
| September 30, 2018 | 272.40M |
| June 30, 2018 | 207.79M |
| March 31, 2018 | 259.43M |
| December 31, 2017 | 294.43M |
| September 30, 2017 | 375.68M |
| June 30, 2017 | 440.86M |
| March 31, 2017 | 400.52M |
| December 31, 2016 | 437.52M |
| September 30, 2016 | 346.91M |
| June 30, 2016 | 286.07M |
| March 31, 2016 | 253.28M |
| December 31, 2015 | 321.28M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Supernus Pharmaceuticals, Inc. | 19.91M |
| Liquidia Corp. | 167.71M |
| Corcept Therapeutics, Inc. | 109.70M |
| Prestige Consumer Healthcare, Inc. | 249.40M |
| Harrow, Inc. | 6.252M |